Search academic texts

Head: Lialkin Serhii A.. Improving the results of conservative treatment of breast cancer patients with low or negative HER2/neu status based on optimization and individualization of therapy methods. (popup.stage: Вивчити вплив хемокіну CCR5 та експресії TKS4 і PDL-1 на терміни до прогресування захворювання після курсу стандартної НАХТ у хворих на рак грудної залози з низьким або негативним статусом HER2/neu.). National Cancer Institute. № 0225U001208

Head: Kriachok Iryna A.. Optimize the diagnosis and treatment of patients with non-Hodgkin's lymphoma of T-cell origin.. (popup.stage: ). National Cancer Institute. № 0224U002953

Head: Kriachok Iryna A.. Optimize the diagnosis and treatment of patients with non-Hodgkin's lymphoma of T-cell origin.. (popup.stage: ). National Cancer Institute. № 0223U002393

Head: Kriachok Iryna A.. Optimize the diagnosis and treatment of patients with non-Hodgkin's lymphoma of T-cell origin.. (popup.stage: ). National Cancer Institute. № 0222U003716

Head: Kriachok Iryna A.. Improve the treatment of primary lymphoma patients with B cellular origin. (popup.stage: ). National Cancer Institute. № 0221U106404

Head: Kriachok Iryna A. Improve the treatment of primary lymphoma patients with B cellular origin. (popup.stage: ). National Cancer Institute. № 0220U102620

Aleksyk Olena. Optimization of combined treatment methods in patients with small-cell non-Hodgkin's lymphomas according to presence of unfavorable prognostic factors of disease course : к.мед.н. : spec.. 14.01.07 - Онкологія : presented. 2015-06-10; popup.evolution: .; Ukrainian Research Institute of Oncology and Radiology. – , 0415U005007.

Head: Smolanka Ivan Ivanovich. The work out the algorithm of complex treatment of patients with locally advanced breast cancer. (popup.stage: ). Ukrainian Research Institute of Oncology and Radiology. № 0215U003247

Head: Kryachok Iryna. To determine molecular changes in cancer cells of the patients with refractory forms of malignant lymphomas, to define diagnostic and prognostic value of these changes, to develop the methods of treatment depend on levels of these changes.. (popup.stage: ). Ukrainian Research Institute of Oncology and Radiology. № 0211U006180

Head: Kryachok Iryna. To determine molecular changes in cancer cells of the patients with refractory forms of malignant lymphomas, to define diagnostic and prognostic value of these changes, to develop the methods of treatment depend on levels of these changes.. (popup.stage: Розробити оптимальні методи лікування хворих на рефрактерні злоякісні лімфоми з урахуванням рівня експресії РКС). Nacional Cancer Institute. № 0310U002014